DEVICE CATEGORY · SBY
High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids
A high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids is a qualitative in vitro diagnostic test intended for next generation sequencing analysis of circulating cell-free nucleic acids from plasma samples collected from peripheral whole blood to detect mutations in a panel of targeted genes to aid in the management of previously diagnosed cancer patients by qualified health care professionals. The results of the test are not prescriptive or conclusive for use of any specific therapeutic product.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Oncomine Dx Express TestK260827 | Life Technologies Corporation | 510(k) clearance | Oct 15, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
